Free Trial

Estée Lauder Companies (EL) Competitors

Estée Lauder Companies logo
$65.34 +0.55 (+0.85%)
(As of 11/20/2024 ET)

EL vs. PBH, IPAR, HLF, USNA, NUS, NATR, MED, VERU, CL, and KVUE

Should you be buying Estée Lauder Companies stock or one of its competitors? The main competitors of Estée Lauder Companies include Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Colgate-Palmolive (CL), and Kenvue (KVUE).

Estée Lauder Companies vs.

Estée Lauder Companies (NYSE:EL) and Prestige Consumer Healthcare (NYSE:PBH) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, community ranking, profitability, institutional ownership, valuation and earnings.

55.2% of Estée Lauder Companies shares are owned by institutional investors. Comparatively, 100.0% of Prestige Consumer Healthcare shares are owned by institutional investors. 12.8% of Estée Lauder Companies shares are owned by insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Estée Lauder Companies has higher revenue and earnings than Prestige Consumer Healthcare. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Estée Lauder Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Estée Lauder Companies$15.61B1.50$390M$0.56116.68
Prestige Consumer Healthcare$1.13B3.63$209.34M$4.1120.11

Prestige Consumer Healthcare has a net margin of 18.54% compared to Estée Lauder Companies' net margin of 1.31%. Estée Lauder Companies' return on equity of 17.31% beat Prestige Consumer Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Estée Lauder Companies1.31% 17.31% 4.25%
Prestige Consumer Healthcare 18.54%12.23%6.14%

Estée Lauder Companies has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500.

Estée Lauder Companies received 701 more outperform votes than Prestige Consumer Healthcare when rated by MarketBeat users. However, 70.77% of users gave Prestige Consumer Healthcare an outperform vote while only 68.35% of users gave Estée Lauder Companies an outperform vote.

CompanyUnderperformOutperform
Estée Lauder CompaniesOutperform Votes
1190
68.35%
Underperform Votes
551
31.65%
Prestige Consumer HealthcareOutperform Votes
489
70.77%
Underperform Votes
202
29.23%

In the previous week, Estée Lauder Companies had 19 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 26 mentions for Estée Lauder Companies and 7 mentions for Prestige Consumer Healthcare. Estée Lauder Companies' average media sentiment score of 0.95 beat Prestige Consumer Healthcare's score of 0.40 indicating that Estée Lauder Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Estée Lauder Companies
18 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Prestige Consumer Healthcare
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Estée Lauder Companies currently has a consensus price target of $98.57, indicating a potential upside of 50.86%. Prestige Consumer Healthcare has a consensus price target of $83.67, indicating a potential upside of 1.21%. Given Estée Lauder Companies' higher probable upside, analysts clearly believe Estée Lauder Companies is more favorable than Prestige Consumer Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estée Lauder Companies
0 Sell rating(s)
18 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.18
Prestige Consumer Healthcare
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

Estée Lauder Companies beats Prestige Consumer Healthcare on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EL vs. The Competition

MetricEstée Lauder CompaniesToilet preparations IndustryStaples SectorNYSE Exchange
Market Cap$23.46B$11.78B$14.47B$19.90B
Dividend Yield4.14%3.18%2.68%3.54%
P/E Ratio116.6831.4123.8042.67
Price / Sales1.5019.6998.1718.14
Price / Cash12.9919.0519.1417.85
Price / Book4.4111.335.975.60
Net Income$390M$353.66M$579.55M$985.93M
7 Day Performance3.95%1.10%-0.53%-0.19%
1 Month Performance-27.43%-0.83%-3.91%0.15%
1 Year Performance-46.64%11.24%9.42%23.70%

Estée Lauder Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EL
Estée Lauder Companies
4.9224 of 5 stars
$65.34
+0.8%
$98.57
+50.9%
-46.6%$23.46B$15.61B116.6862,000Analyst Forecast
Insider Trade
PBH
Prestige Consumer Healthcare
3.3849 of 5 stars
$82.67
+0.3%
$83.67
+1.2%
+40.5%$4.07B$1.13B20.11540
IPAR
Inter Parfums
3.8214 of 5 stars
$127.12
+1.6%
$157.50
+23.9%
+1.8%$4.01B$1.42B27.28530
HLF
Herbalife
4.1247 of 5 stars
$8.42
+8.9%
$9.90
+17.6%
-33.5%$848.17M$5.00B9.669,200
USNA
USANA Health Sciences
2.8323 of 5 stars
$39.52
+1.2%
$35.00
-11.4%
-14.5%$744.09M$921.01M13.961,800
NUS
Nu Skin Enterprises
3.6991 of 5 stars
$7.49
-1.3%
$8.88
+18.5%
-57.3%$377.31M$1.97B0.003,700
NATR
Nature's Sunshine Products
2.7901 of 5 stars
$16.00
+0.2%
$19.00
+18.8%
-7.5%$295.68M$445.32M18.18814Positive News
MED
Medifast
2.513 of 5 stars
$18.18
+5.0%
$17.00
-6.5%
-73.1%$189.44M$1.07B27.55870Positive News
VERU
Veru
2.3517 of 5 stars
$0.63
flat
$4.00
+539.7%
-36.6%$91.81M$16.30M0.00189Gap Up
CL
Colgate-Palmolive
4.8566 of 5 stars
$93.91
+0.3%
$105.11
+11.9%
+24.4%$76.73B$20.11B26.9134,000Positive News
KVUE
Kenvue
3.104 of 5 stars
$23.78
+0.4%
$22.64
-4.8%
+20.4%$45.59B$15.44B43.2422,000Positive News

Related Companies and Tools


This page (NYSE:EL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners